Nerviano Medical Sciences S.r.l.

Pfizer Italia S.r.l.

Pharmacia Italia S.p.a.

Maria Gabriella Brasca

Barbara Salom

William John Trigg

Edward Andrew Boyd

Frederick Arthur Brookfield

Jonathan Anthony Larard

Patrizia Giordano

Matteo D'anello

Katia Martina

Dania Tesei

Mario Varasi

Daniele Fancelli

Paola Vianello

Matteo D'Anello

Simona Bindi

Sergio Vioglio

Thieno[2,3-c]pyrazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.

1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors

Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.

Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors

Pyrrolo[2,3-B]pyridine derivatives active as kinase inhibitors

Growing community of inventors

Ancona, Italy

Dania Tesei